| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ab457411ff5eab18e87c72daf302278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78160fe5924d399deb065f8cbc5ad347 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4433 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4433 |
| filingDate |
2021-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d7022f0ca44053d494260970c0de017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b02eaffca13326e8e44145664d8b380f |
| publicationDate |
2022-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022111670-A1 |
| titleOfInvention |
Use of tipranavir in preparing cancer therapy drugs for killing tumor stem cells and tumor cells |
| abstract |
A use of Tipranavir in preparing cancer therapy drugs for killing tumor stem cells and tumor cells. Therapeutic drugs for cancer, the drugs being capable of killing tumor stem cells and tumor cells. The drugs use Tipranavir as a main active ingredient, and contain a pharmaceutically acceptable carrier. Tipranavir can be used for preparing anti-cancer drugs for killing tumor stem cells and tumor cells, and has no obvious toxic side effects. |
| priorityDate |
2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |